Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Barbara A. Prillaman"'
Autor:
Anahi Yanez M.D., Alex Dimitroff B.Pharm., Peter Bremner M.D., Chae-Seo Rhee M.D., Ph.D., Graham Luscombe Ph.D., Barbara A. Prillaman M.S., M.A., Neil Johnson B.Sc.
Publikováno v:
Allergy & Rhinology, Vol 7 (2016)
Background Corticosteroid nasal sprays are the mainstay of treatment for allergic rhinitis. These sprays have sensory attributes such as scent and/or odor, taste and aftertaste, and run down the throat and/or the nose, which, when unpleasant, can aff
Externí odkaz:
https://doaj.org/article/8c1799c6ba124fa49b19b6c4a34c08ef
Publikováno v:
Chest. 158(3)
Background COPD is the second most common cause of hospital admission in the United States. OSA is a highly prevalent and underdiagnosed condition that may affect the outcome of COPD. Research Question We hypothesized that presence of unrecognized an
Autor:
David A, Stempel, Stanley J, Szefler, Søren, Pedersen, Robert S, Zeiger, Anne M, Yeakey, Laurie A, Lee, Andrew H, Liu, Herman, Mitchell, Kenneth M, Kral, Ibrahim H, Raphiou, Barbara A, Prillaman, Kathleen S, Buaron, Suyong, Yun Kirby, Steven J, Pascoe, John F, Zwetchkenbaum
Publikováno v:
Stempel, D A, Szefler, S J, Pedersen, S, Zeiger, R S, Yeakey, A M, Lee, L A, Liu, A H, Mitchell, H, Kral, K M, Raphiou, I H, Prillaman, B A, Buaron, K S, Yun Kirby, S Y K & Pascoe, S J 2016, ' Safety of adding salmeterol to fluticasone propionate in children with asthma ', The New England Journal of Medicine, vol. 375, no. 9, pp. 840-849 . https://doi.org/10.1056/NEJMoa1606356
BACKGROUND Long-acting beta-agonists (LABAs) have been shown to increase the risk of asthmarelated death among adults and the risk of asthma-related hospitalization among children. It is unknown whether the concomitant use of inhaled glucocorticoids
Publikováno v:
Allergy and Asthma Proceedings. 36:313-319
Intranasal corticosteroids are generally considered the most effective medication class for controlling allergic rhinitis. Previous comparative studies with oral antihistamines have been only partially informative due to a variety of variables encoun
Autor:
James E. Gern, Steven F. Weinstein, Barbara A. Prillaman, David A. Stempel, Charlene M. Prazma
Publikováno v:
Respiratory Medicine
Background A seasonal peak in asthma exacerbations in the fall has previously been reported. The association between fall exacerbations and viral respiratory tract infections (RTI) remains uncertain. Objective To investigate the number of fall exacer
Autor:
Maria Mancuso, Amanda Emmett, Barbara A. Prillaman, Carlotte Baidoo, Noushin Brealey, Kenneth M. Kral, Ibrahim Raphiou, Steven Pascoe
Publikováno v:
Allergy and immunology.
Introduction: Two recently completed large-scale safety studies provide an opportunity to assess inhaled corticosteroid (ICS) doses with regard to the incidence of asthma exacerbations and serious adverse events (SAE). Methods: Ad hoc ICS dose subgro
Autor:
Graham Luscombe, Peter R. Bremner, Neil Johnson, Barbara A. Prillaman, Anahi Yanez, Alex Dimitroff, Chae-Seo Rhee
Publikováno v:
Allergy & Rhinology
Allergy & Rhinology, Vol 7 (2016)
Allergy & Rhinology, Vol 7 (2016)
Background Corticosteroid nasal sprays are the mainstay of treatment for allergic rhinitis. These sprays have sensory attributes such as scent and/or odor, taste and aftertaste, and run down the throat and/or the nose, which, when unpleasant, can aff
Autor:
Ibrahim Raphiou, Steven Pascoe, Anne Yeakey, Kenneth M. Kral, Søren Pedersen, Robert S. Zeiger, Suyong Yun Kirby, Laurie Lee, Barbara A. Prillaman, D. Stempel, Andrew H. Liu, Kathleen S. Buaron, Herman Mitchell, Stanley J. Szefler
Publikováno v:
7.2 Paediatric Asthma and Allergy.
Background: Studies have shown an excess of serious asthma events in subjects taking long-acting β 2 -agonist (LABAs). In children the excess was in hospitalizations but studies were not designed to detect if risk is mitigated with concomitant use o
Autor:
Nicola A. Hanania, Lori McLeod, Barbara A. Prillaman, Glenn Crater, Ibrahim Raphiou, Michael J. Cicale, Catherine A. Grellet, Matthew Mintz, Alicia Gilsenan, James F. Donohue, Barbara P. Yawn, Douglas W. Mapel, Anand A. Dalal, David M. Mannino
Publikováno v:
Mayo Clinic Proceedings. 86:375-381
OBJECTIVE To estimate the prevalence of unidentified chronic obstructive pulmonary disease (COPD) and determine the screening accuracy of the Lung Function Questionnaire (LFQ). PATIENTS AND METHODS Cigarette smokers who had a smoking history of 10 or
Autor:
Barbara A. Prillaman, Edward E. Philpot, Glen E. Journeay, Cindy Garris, Charles P. Andrews, Junghee Lim, Eli O. Meltzer
Publikováno v:
Annals of Allergy, Asthma & Immunology. 104:331-338
Intranasal corticosteroids are first-line treatment for moderate-to-severe seasonal allergic rhinitis (AR).To compare preferences for fluticasone furoate and fluticasone propionate nasal sprays after 1 week of treatment in patients with symptomatic s